The Prognostic Value of AT-Rich Interaction Domain (ARID) Family Members in Patients with Hepatocellular Carcinoma
出版年份 2022 全文链接
标题
The Prognostic Value of AT-Rich Interaction Domain (ARID) Family Members in Patients with Hepatocellular Carcinoma
作者
关键词
-
出版物
Evidence-based Complementary and Alternative Medicine
Volume 2022, Issue -, Pages 1-16
出版商
Hindawi Limited
发表日期
2022-08-19
DOI
10.1155/2022/1150390
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment
- (2022) Wei Tan et al. Computational and Mathematical Methods in Medicine
- Expression Signature of the AT-Rich Interactive Domain Gene Family Identified in Digestive Cancer
- (2022) Yongqu Lu et al. Frontiers in Medicine
- Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy
- (2022) Yan Zhu et al. CANCER BIOLOGY & THERAPY
- The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma
- (2022) Sha Qin et al. DISEASE MARKERS
- Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma
- (2022) Ji Sun et al. Journal of Immunology Research
- Expression and prognostic values of ARID family members in breast cancer
- (2021) Jinfeng Zhang et al. Aging-US
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- KDM5A silencing transcriptionally suppresses the FXYD3‐PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR‐433 up‐regulation
- (2021) Yu‐Shui Ma et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- KDM5B promotes self‐renewal of hepatocellular carcinoma cells through the microRNA‐448–mediated YTHDF3/ITGA6 axis
- (2021) Jun‐Cheng Guo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma
- (2021) Quan Zhou et al. Frontiers in Oncology
- Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis
- (2021) Zhulin Wu et al. Frontiers in Molecular Biosciences
- ARID1A deficiency and immune checkpoint blockade therapy: From mechanisms to clinical application
- (2020) Guangyuan Hu et al. CANCER LETTERS
- ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells
- (2020) Paige Dausinas et al. GENE
- Systematic Elucidation of the Potential Mechanisms of Core Chinese Materia Medicas in Treating Liver Cancer Based on Network Pharmacology
- (2020) Zhulin Wu et al. Evidence-based Complementary and Alternative Medicine
- Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer
- (2020) Poonam Sarode et al. Science Advances
- Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment
- (2020) Zhulin Wu et al. Frontiers in Molecular Biosciences
- KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male
- (2019) Xudong Shen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- Wnt/β-Catenin Signaling in Liver Cancers
- (2019) Wenhui Wang et al. Cancers
- Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating β-catenin
- (2019) Yuetong Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells
- (2018) Yue Ma et al. BIOMEDICINE & PHARMACOTHERAPY
- Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma
- (2018) Rongchang Wang et al. HUMAN PATHOLOGY
- Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer
- (2018) Ying-Ke Liang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data
- (2018) Vijayachitra Modhukur et al. Epigenomics
- Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
- (2018) Ádám Nagy et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gain of UBE2D1 facilitates hepatocellular carcinoma progression and is associated with DNA damage caused by continuous IL-6
- (2018) Chuanchuan Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
- (2018) Otília Menyhárt et al. Royal Society Open Science
- ARID2 modulates DNA damage response in human hepatocellular carcinoma cells
- (2017) Atsushi Oba et al. JOURNAL OF HEPATOLOGY
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- A potentially functional variant of ARID1B interacts with physical activity in association with risk of hepatocellular carcinoma
- (2017) Li Liu et al. Oncotarget
- Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma
- (2017) Francesca Pezzuto et al. Infectious Agents and Cancer
- Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma
- (2016) Takahiro Kodama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling
- (2016) Xiong Lei et al. Oncotarget
- Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell invasion through inhibition BMP7 expression
- (2015) Xuening Ji et al. BMC CANCER
- Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma
- (2015) Yu Guo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Recent advances in the ARID family: focusing on roles in human cancer
- (2014) Zhao Hong et al. OncoTargets and Therapy
- The functional interactome landscape of the human histone deacetylase family
- (2013) P. Joshi et al. Molecular Systems Biology
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators
- (2012) Akihiro Fujimoto et al. NATURE GENETICS
- Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
- (2011) Meng Li et al. NATURE GENETICS
- A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
- (2010) S. Roessler et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now